Physician profile
George E Patton
NPI 1003914813
$4,682.05
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $923 · 2021: $1,293 · 2022: $1,162 · 2023: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $776.04 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $468.56 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Novo Nordisk INC | $422.75 | 2019-2023 | Ozempic, Rybelsus |
| Pfizer INC. | $294.60 | 2019-2021 | |
| Lilly USA, LLC | $237.15 | 2020-2023 | Mounjaro |
| Amgen INC. | $230.18 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $192.41 | 2021-2023 | |
| Astellas Pharma US INC | $189.14 | 2019-2023 | Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.02 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.63 | 2019-2023 | Xifaxan, Trulance |
| Allergan, INC. | $152.34 | 2019-2020 | |
| Abbott Laboratories | $145.93 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $118.47 | 2020-2022 | |
| Amarin Pharma, INC. | $108.23 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $106.21 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.